Published by Josh White on 25th March 2024
(Sharecast News) - Monoclonal antibody specialist BioVentix reported a 13% rise in first-half revenue on Monday, to £6.7m, compared to £5.9m in the prior year.
URL: http://www.digitallook.com/dl/news/story/34178043/...